COURTNEY BROWN: Open Payments
NPI 1235714999 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,689 in 223 payments from 29 companies in 2025. Trend: 2023 $2,586 · 2024 $3,106 · 2025 $3,689
Food & beverage: $3,689
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $712 |
| PFIZER INC. | 52 | $566 |
| ARGENX US, INC. | 9 | $274 |
| Merz Pharmaceuticals, LLC | 9 | $206 |
| ACADIA Pharmaceuticals Inc | 11 | $205 |
| Janssen Biotech, Inc. | 7 | $195 |
| UCB, Inc. | 10 | $188 |
| Otsuka America Pharmaceutical, Inc. | 7 | $178 |
| Neurocrine BioSciences, Inc. | 7 | $167 |
| Amgen Inc. | 7 | $112 |
Products named: NURTEC ODT, QULIPTA, BOTOX, Xeomin, NUPLAZID, REXULTI, UBRELVY, INGREZZA.
Industry payments across AL — which companies pay providers there.
